300 lines
13 KiB
JSON
300 lines
13 KiB
JSON
[
|
|
{
|
|
"uid": 1,
|
|
"id": 1447203401,
|
|
"Salutation": "Dr.",
|
|
"First Name": "Roxana",
|
|
"Middle Name": "",
|
|
"Last Name": "Mehran",
|
|
"name": "Dr. Roxana Mehran",
|
|
"p_suffix": "MD,FACC,FACP,FCCP,FESC,FAHA,FSCAI",
|
|
"speciality": "Cardiovascular Disease (Cardiology)",
|
|
"sub_speciality": "",
|
|
"OrgName": "Icahn School of Medicine at Mount Sinai",
|
|
"Division": "",
|
|
"Title": "",
|
|
"License #": "NY: 185790",
|
|
"NPI Number": 1447203401,
|
|
"Profile Type": "Basic Profile",
|
|
"Url": "",
|
|
"Org ID": 256884,
|
|
"summarry": "• 41 Years of experience\n• Studied in New York University, St. George's University Medical School\n• Icahn School Of Medicine At Mount Sinai, Medstar Washington Hospital Center and 111 other affiliations\n• Speaker in 442 sessions in conferences\n• 909 Publications with 274 articles as lead author\n• Investigator in 23 clinical studies\n• Received payments from Abbott Laboratories, Amgen Inc., Astrazeneca Pharmaceuticals Lp and 23 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None",
|
|
"phone_no": "+12127317822",
|
|
"Fax": "+12127317822",
|
|
"email": "roxana.mehran@mountsinai.org",
|
|
"Address1": "1 Gustave L Levy Pl",
|
|
"Address2": "",
|
|
"City": "New York",
|
|
"State": "New York",
|
|
"PostalCode": 10029,
|
|
"Country": "United States",
|
|
"img_path": "",
|
|
"event_topics": "Heart Failure | Heart Diseases | Heart Failure, Systolic",
|
|
"pub_topics": "Heart Failure | Diabetes Mellitus, Type 2 | Cardiovascular Diseases",
|
|
"products_discussed": "VERQUVO | JARDIANCE | JARDIANCE",
|
|
"disease_conditions": "",
|
|
"drugs": "",
|
|
"topdata": [
|
|
{
|
|
"title": "Top Event Topics",
|
|
"name1": "Heart Failure",
|
|
"name2": "Heart Diseases",
|
|
"name3": "Heart Failure, Systolic"
|
|
},
|
|
{
|
|
"title": "Top Publication Topics",
|
|
"name1": "Heart Failure",
|
|
"name2": "Diabetes Mellitus, Type 2",
|
|
"name3": "Cardiovascular Diseases"
|
|
},
|
|
{
|
|
"title": "Top Products Discussed",
|
|
"name1": "VERQUVO",
|
|
"name2": "JARDIANCE",
|
|
"name3": "JARDIANCE"
|
|
}
|
|
]
|
|
},
|
|
{
|
|
"uid": 2,
|
|
"id": 1639100928,
|
|
"Salutation": "Dr.",
|
|
"First Name": "Javed",
|
|
"Middle Name": "",
|
|
"Last Name": "Butler",
|
|
"name": "Dr. Javed Butler",
|
|
"p_suffix": "MD,MPH,MBA,FACC,FAHA",
|
|
"speciality": "Cardiovascular Disease (Cardiology)",
|
|
"sub_speciality": "Advanced Heart Failure And Transplant Cardiology",
|
|
"OrgName": "Baylor Scott & White Health",
|
|
"Division": "",
|
|
"Title": "",
|
|
"License #": "MS: 26174,TN: 31361",
|
|
"NPI Number": 1639100928,
|
|
"Profile Type": "Basic Profile",
|
|
"Url": "",
|
|
"Org ID": 23726,
|
|
"summarry": "• 34 Years of experience\n• Studied in Emory University Goizueta Business School, Harvard T.h. Chan School Of Public Health\n• Baylor Scott & White Health, University Of Mississippi Medical Center and 38 other affiliations\n• Speaker in 209 sessions in conferences\n• 1087 Publications with 299 articles as lead author\n• Investigator in 10 clinical studies\n• Received payments from Abbott Laboratories, American Regent, Amgen Inc. and 61 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents",
|
|
"phone_no": "+12148202687",
|
|
"Fax": "+16316384170",
|
|
"email": "javed.butler@bswhealth.org",
|
|
"Address1": "3434 Live Oak St",
|
|
"Address2": "",
|
|
"City": "Dallas",
|
|
"State": "Texas",
|
|
"PostalCode": 75204,
|
|
"Country": "United States",
|
|
"img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1639100928.jpeg",
|
|
"event_topics": "Atherosclerosis | Coronary Artery Disease | Computed Tomography Angiography",
|
|
"pub_topics": "Coronary Artery Disease | Atherosclerosis | Vascular Calcification",
|
|
"products_discussed": "VERQUVO | FARXIGA | Rybelsus",
|
|
"disease_conditions": "Angina Pectoris | Coronary Artery Disease | Heart Diseases",
|
|
"drugs": "Amlodipine Besylate | Metoprolol Succinate | Atorvastatin Calcium",
|
|
"topdata": [
|
|
{
|
|
"title": "Top Event Topics",
|
|
"name1": "Atherosclerosis",
|
|
"name2": "Coronary Artery Disease",
|
|
"name3": "Computed Tomography Angiography"
|
|
},
|
|
{
|
|
"title": "Top Publication Topics",
|
|
"name1": "Coronary Artery Disease",
|
|
"name2": "Atherosclerosis",
|
|
"name3": "Vascular Calcification"
|
|
},
|
|
{
|
|
"title": "Top Products Discussed",
|
|
"name1": "VERQUVO",
|
|
"name2": "FARXIGA",
|
|
"name3": "Rybelsus"
|
|
},
|
|
{
|
|
"title": "Condition Treated",
|
|
"name1": "Angina Pectoris",
|
|
"name2": "Coronary Artery Disease",
|
|
"name3": "Heart Diseases"
|
|
},
|
|
{
|
|
"title": "Drugs Prescribed",
|
|
"name1": "Amlodipine Besylate",
|
|
"name2": "Metoprolol Succinate",
|
|
"name3": "Atorvastatin Calcium"
|
|
}
|
|
]
|
|
},
|
|
{
|
|
"uid": 3,
|
|
"id": 1811967433,
|
|
"Salutation": "Dr.",
|
|
"First Name": "Matthew",
|
|
"Middle Name": "J",
|
|
"Last Name": "Budoff",
|
|
"name": "Dr. Matthew J Budoff",
|
|
"p_suffix": "MD,FACC,FAHA",
|
|
"speciality": "Cardiovascular Disease (Cardiology)",
|
|
"sub_speciality": "",
|
|
"OrgName": "UCLA Santa Monica Medical Center",
|
|
"Division": "",
|
|
"Title": "",
|
|
"License #": "CA: G72496",
|
|
"NPI Number": 1811967433,
|
|
"Profile Type": "Basic Profile",
|
|
"Url": "",
|
|
"Org ID": 20514,
|
|
"summarry": "• 34 Years of experience\n• Studied in George Washington University School Of Medicine And Health Sciences, University Of California, Riverside\n• UCLA Santa Monica Medical Center, Prairie Du Chien Memorial Hospital Association, Inc. and 32 other affiliations\n• Speaker in 179 sessions in conferences\n• 992 Publications with 306 articles as lead author\n• Investigator in 25 clinical studies\n• Received payments from Abbott Laboratories, Actelion Pharmaceuticals Us, Inc., Actelion Pharmaceuticals, Ltd and 44 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents",
|
|
"phone_no": "+16083572000",
|
|
"Fax": "+13102224107",
|
|
"email": "Budoff@ucla.edu",
|
|
"Address1": "10833 Le Conte Ave",
|
|
"Address2": "",
|
|
"City": "Los Angeles",
|
|
"State": "California",
|
|
"PostalCode": 90095,
|
|
"Country": "United States",
|
|
"img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1811967433.jpeg",
|
|
"event_topics": "Tricuspid Valve Insufficiency | Transcatheter Aortic Valve Replacement | Tricuspid Valve",
|
|
"pub_topics": "Aortic Valve Stenosis | Tricuspid Valve Insufficiency | Mitral Valve Insufficiency",
|
|
"products_discussed": "(9520) IGT Devices Undivided | VersaCross Access Solution | MITRACLIP",
|
|
"disease_conditions": "",
|
|
"drugs": "",
|
|
"topdata": [
|
|
{
|
|
"title": "Top Event Topics",
|
|
"name1": "Tricuspid Valve Insufficiency",
|
|
"name2": "Transcatheter Aortic Valve Replacement",
|
|
"name3": "Tricuspid Valve"
|
|
},
|
|
{
|
|
"title": "Top Publication Topics",
|
|
"name1": "Aortic Valve Stenosis",
|
|
"name2": "Tricuspid Valve Insufficiency",
|
|
"name3": "Mitral Valve Insufficiency"
|
|
},
|
|
{
|
|
"title": "Top Products Discussed",
|
|
"name1": "(9520) IGT Devices Undivided",
|
|
"name2": "VersaCross Access Solution",
|
|
"name3": "MITRACLIP"
|
|
}
|
|
]
|
|
},
|
|
{
|
|
"uid": 4,
|
|
"id": 1497893077,
|
|
"Salutation": "Dr.",
|
|
"First Name": "Rebecca",
|
|
"Middle Name": "Tung",
|
|
"Last Name": "Hahn",
|
|
"name": "Dr. Rebecca Tung Hahn",
|
|
"p_suffix": "MD",
|
|
"speciality": "Cardiovascular Disease (Cardiology)",
|
|
"sub_speciality": "Internal Medicine",
|
|
"OrgName": "Columbia University Irving Medical Center",
|
|
"Division": "",
|
|
"Title": "",
|
|
"License #": "NY: 163707",
|
|
"NPI Number": 1497893077,
|
|
"Profile Type": "Basic Profile",
|
|
"Url": "",
|
|
"Org ID": 22909,
|
|
"summarry": "• 40 Years of experience\n• Studied in Washington University School Of Medicine In St. Louis, Harvard University\n• Columbia University Irving Medical Center, Newyork-presbyterian Queens Hospital and 23 other affiliations\n• Speaker in 549 sessions in conferences\n• 427 Publications with 136 articles as lead author\n• Investigator in 7 clinical studies\n• Received payments from Abbott Laboratories, Baylis Medical Company Inc, Boston Scientific Corporation and 5 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None",
|
|
"phone_no": "+12123420444",
|
|
"Fax": "",
|
|
"email": "rth2@cumc.columbia.edu",
|
|
"Address1": "161 Fort Washington Avenue",
|
|
"Address2": "",
|
|
"City": "New York",
|
|
"State": "New York",
|
|
"PostalCode": 10032,
|
|
"Country": "United States",
|
|
"img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1497893077.jpeg",
|
|
"event_topics": "",
|
|
"pub_topics": "",
|
|
"products_discussed": "",
|
|
"disease_conditions": "",
|
|
"drugs": "",
|
|
"topdata": [
|
|
{
|
|
"title": "Top Event Topics",
|
|
"name1": "Tricuspid Valve Insufficiency",
|
|
"name2": "Transcatheter Aortic Valve Replacement",
|
|
"name3": "Tricuspid Valve"
|
|
},
|
|
{
|
|
"title": "Top Publication Topics",
|
|
"name1": "Aortic Valve Stenosis",
|
|
"name2": "Tricuspid Valve Insufficiency",
|
|
"name3": "Mitral Valve Insufficiency"
|
|
}
|
|
]
|
|
},
|
|
{
|
|
"uid": 5,
|
|
"id": 1841382421,
|
|
"Salutation": "Dr.",
|
|
"First Name": "Andrea",
|
|
"Middle Name": "",
|
|
"Last Name": "Natale",
|
|
"name": "Dr. Andrea Natale",
|
|
"p_suffix": "MD",
|
|
"speciality": "Clinical Cardiac Electrophysiology",
|
|
"sub_speciality": "Cardiovascular Disease (Cardiology), Internal Medicine",
|
|
"OrgName": "Texas Cardiac Arrhythmia Institute",
|
|
"Division": "",
|
|
"Title": "",
|
|
"License #": "CA: C50726,TX: M9533,OH: 35076775N",
|
|
"NPI Number": 1841382421,
|
|
"Profile Type": "Basic Profile",
|
|
"Url": "",
|
|
"Org ID": 24328,
|
|
"summarry": "• 39 Years of experience\n• Studied in Università Degli Studi Di Firenze Facoltà Di Medicina E Chirurgia\n• Texas Cardiac Arrhythmia Institute, Golden State Providers, A Medical Corporation and 110 other affiliations\n• Speaker in 1091 sessions in conferences\n• 542 Publications with 213 articles as lead author\n• Investigator in 80 clinical studies\n• Received payments from Abbott Laboratories, Acclarent, Inc, Acutus Medical, Inc. and 32 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents",
|
|
"phone_no": "+15128073150",
|
|
"Fax": "+15124587879",
|
|
"email": "andrea.natale@hcahealthcare.com",
|
|
"Address1": "3000 N. IH-35",
|
|
"Address2": "Suite 720",
|
|
"City": "Austin",
|
|
"State": "Texas",
|
|
"PostalCode": 78705,
|
|
"Country": "United States",
|
|
"img_path": "",
|
|
"event_topics": "Ablation Techniques | Atrial Fibrillation | Catheter Ablation",
|
|
"pub_topics": "Atrial Fibrillation | Recurrence | Tachycardia, Ventricular",
|
|
"products_discussed": "CARTO 3 | WATCHMAN Access System | ENSITE PRECISION",
|
|
"disease_conditions": "Angina Pectoris | Coronary Artery Disease | Hypertension",
|
|
"drugs": "Eliquis | Xarelto | Furosemide",
|
|
"topdata": [
|
|
{
|
|
"title": "Top Event Topics",
|
|
"name1": "Ablation Techniques",
|
|
"name2": "Atrial Fibrillation",
|
|
"name3": "Catheter Ablation"
|
|
},
|
|
{
|
|
"title": "Top Publication Topics",
|
|
"name1": "CARTO 3",
|
|
"name2": "WATCHMAN Access System",
|
|
"name3": "ENSITE PRECISION"
|
|
},
|
|
{
|
|
"title": "Top Products Discussed",
|
|
"name1": "CARTO 3",
|
|
"name2": "WATCHMAN Access System",
|
|
"name3": "RybeENSITE PRECISIONlsus"
|
|
},
|
|
{
|
|
"title": "Condition Treated",
|
|
"name1": "Angina Pectoris",
|
|
"name2": "Coronary Artery Disease",
|
|
"name3": "Hypertension"
|
|
},
|
|
{
|
|
"title": "Drugs Prescribed",
|
|
"name1": "Eliquis",
|
|
"name2": "Xarelto",
|
|
"name3": "Furosemide"
|
|
}
|
|
]
|
|
}
|
|
] |